MERCK MARKET SHARE ON MEDCO FORMULARIES REACHES 12%, UP FROM 10%; MERCK WILL NOT BROADEN PRODUCT LINE TO MAINTAIN MARKET SHARE, CEO GILMARTIN TELLS NYSSA
Executive Summary
Merck products have climbed to a 12% share of Medco formulary product sales, Merck Chairman and CEO Ray Gilmartin told a meeting of the New York Society of Security Analysts Nov. 29.